7: Per cent test positivity in the community that targets both the original strain of COVID-19 and the Omicron variant.Article contentThose are in addition to 1.5 million doses expected to arrive this year. The doses were originally scheduled to arrive in 2023, but that has been pushed ahead.
The agreement depends on Health Canada’s approval of the company’s bivalent vaccine, which was submitted for review on June 30. In the capital, COVID-19 indicators are starting to decline and “that’s encouraging,” Public Health said in a weekly “snapshot” Thursday.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: